Novartis | NOVN - Stock

Aktienkurs
114.72
Täglich Wechseln
0.64 0.56%
Monatlich
-4.26%
Jährlich
21.77%
Q2 Prognose
111.47




Stock Veränderung Datum
AbbVie USD 4.95B 13M 2025-12
Alcon AG USD 2.39B 3M 2025-12
Almirall EUR 178.13M 1.54M 2025-12
Amgen USD 6.22B 121M 2025-12
AstraZeneca USD 6.59B 126M 2025-09
Autolus Therapeutics Ltd USD 33.21M 5.49M 2025-12
Bayer EUR 12.33B 221M 2025-09
Biogen USD 2.17B 41.3M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Eli Lilly USD 13.74B 1.56B 2025-12
Fresenius EUR 2.59B 44M 2025-06
Fresenius Medical Care EUR 2.14B 54.28M 2025-12
Galapagos EUR 22.95M 15.57M 2025-09
Genmab DKK 13M 1000K 2025-06
Gilead Sciences USD 1.77B 11M 2025-12
GlaxoSmithKline GBP 6.12B 46M 2025-09
GRIFOLS EUR 3.35B 213.23M 2025-06
Hikma Pharmaceutical USD 1.08B 96M 2025-06
J&J USD 14.58B 392M 2026-03
Lonza CHF 1.68B 163M 2025-12
Merck EUR 4.51B 42M 2025-09
Merck USD 6.44B 157M 2025-09
Novartis USD 6.27B 152M 2025-12
Novartis USD 6.42B 114M 2025-09
Novo Nordisk DKK 45.65B 21.26B 2025-06
Orion EUR 456.3M 12.6M 2025-12
Pfizer USD 11.47B 201M 2025-09
Philips EUR 3.26B 28M 2025-09
Recordati EUR 505.2M 11.57M 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12
UCB EUR 1.31B 173M 2024-12